Adjuvant Therapy in Pancreatic Cancer

  • Paula Ghaneh
  • Anthony Kawesha
  • J. D. Evans
  • J. P. Neoptolemos


Pancreatic cancer continues to present a difficult clinical problem with an overall 5-year survival rate of only 0.4% (1,2). Nevertheless, improvements in surgical techniques, supportive care and referrals to specialised centres (3) have resulted in resection rates of 7–14% (4,5) and decreasing operative mortality rates of less than 10%. Yet the median survival time after surgery is only 10–18 months, with overall 5-year survival rates of 10–24% (6–13). In reality this means that very few patients are actually cured in spite of the advances that have been made in conventional treatment (10).


Pancreatic Cancer External Beam Radiation Therapy Advanced Pancreatic Cancer Preoperative Chemoradiation Positive Resection Margin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gudjonsson B (1987) Cancer of the pancreas: 50 years of surgery. Cancer 60:2284–2303.PubMedCrossRefGoogle Scholar
  2. 2.
    Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP (1995) Incidence, treatment and survival in 13,560 patients with pancreatic cancer: an epidemiological study in the West Midlands. Br J Surg 82:111–115.PubMedCrossRefGoogle Scholar
  3. 3.
    Lieberman MD, Kilburn H, Lindsey M, Brennan MF (1995) Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 222:638–645.PubMedCrossRefGoogle Scholar
  4. 4.
    Neiderhuber JE, Brennan MF, Menck HR (1995) The national cancer data base report on pancreatic cancer. Cancer 76:1671–1677.CrossRefGoogle Scholar
  5. 5.
    Wade TP, Halaby I A, Stapleton DR, Virgo KS, Johnson FE (1996) Population-based analysis of treatment of pancreatic cancer and Whipple resection: Department of Defense hospitals 1989–1994. Surgery 120:680–687.PubMedCrossRefGoogle Scholar
  6. 6.
    Grace PA, Pitt HA, Tompkins RK, DenBesten L, Longmire Jr WP (1986) Decreased morbidity and mortality after pancreatectomy. Am J Surg 151:141–149.PubMedCrossRefGoogle Scholar
  7. 7.
    Trede M, Schwall G, Saeger H-D (1990) Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 211:447–458.PubMedCrossRefGoogle Scholar
  8. 8.
    Russell RCG (1990) Surgical resection for cancer of the pancreas. Bailliere’s Clin Gastroenterol 4:889–916.CrossRefGoogle Scholar
  9. 9.
    Cameron JL, Pitt HA, Yeo CJ, Lillimoe KD, Kaufman HS, Coleman J (1993). One hundred and forty five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217:430–438.PubMedCrossRefGoogle Scholar
  10. 10.
    Edge SB, Schmieg Jr R, Rosenlof LK, Willhelm MC (1993) Pancreas cancer resection outcome in American university centers in 1989–1990. Cancer 71:3502–3508.PubMedCrossRefGoogle Scholar
  11. 11.
    Nitecki SS, Sarr MG, Colby TV, Van Heerden JA (1995) Long-term survival after resection for ductal adenocarcinoma of the pancreas. It is really improving? Ann Surg 221:59–66.PubMedCrossRefGoogle Scholar
  12. 12.
    Yeo CJ, Cameron JL, Lillimoe KD et al. (1995) Pancreatoduodenectomy for cancer of the head of the pancreas in 201 patients. Ann Surg 221:721–733.PubMedCrossRefGoogle Scholar
  13. 13.
    Conlon KC, Klimstra DS, Brennan MF (1996) Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5 year survivors. Ann Surg 223:273–279.PubMedCrossRefGoogle Scholar
  14. 14.
    Tepper J, Nardi G, Suit H (1976) Carcinoma of the pancreas: review of MGH experience from 1963 to 1973: analysis of surgical failure and implications for radiation therapy. Cancer 37:1519–1524.PubMedCrossRefGoogle Scholar
  15. 15.
    Pilepich MV, Miller HH (1980) Preoperative irradiation in carcinoma of the pancreas. Cancer 46:1945–1949.PubMedCrossRefGoogle Scholar
  16. 16.
    Kopelson G (1983) Curative surgery for adenocarcinoma of the pancreas/ampulla of Vater: the role of adjuvant pre- or post-operative radiation therapy. Int J Radiat Oncol Biol Phys 9:911–915.PubMedCrossRefGoogle Scholar
  17. 17.
    Ishikawa O, Ohigashi H, Imaoka S et al. (1994) Is the long-term survival rate improved by preoperative irradiation prior to Whipple’s procedure for adenocarcinoma of the pancreatic head? Arch Surg 129:1075–1080.PubMedGoogle Scholar
  18. 18.
    Coia L, Hoffman J, Schier R et al. (1994) Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys 30:161–167.PubMedGoogle Scholar
  19. 19.
    Hoffman JP, Weese JL, Solin LJ et al. (1995) A pilot study of preoperative chemoradiation for patients with localised adenocarcinoma of the pancreas. Am J Surg 169:71–78.PubMedCrossRefGoogle Scholar
  20. 20.
    Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC (1993) Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 217:144–148.PubMedCrossRefGoogle Scholar
  21. 21.
    Evans DB, Rich TA, Byrd DR et al. (1992) Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127:1335–1339.PubMedGoogle Scholar
  22. 22.
    Staley CA, Lee JE, Clearly KR et al. (1996) Preoperative chemoradiation pancreaticoduodenectomy and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171:118–124.PubMedCrossRefGoogle Scholar
  23. 23.
    Tyler DS, Evans DB (1994) Reoperative pancreaticoduodenectomy. Ann Surg 219:211–221.PubMedCrossRefGoogle Scholar
  24. 24.
    Weese JL, Nussbaum ML, Paul AR et al. (1991) Increased resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy. Int J Pancreatol 7:177–185.Google Scholar
  25. 25.
    Sindelar WF (1989) Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 124:127–132.PubMedGoogle Scholar
  26. 26.
    Shibamoto Y, Manabe T, Baba M (1990) High dose external beam and intraoperative radiotherapy in the treatment of resectable and unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 19:605–611.PubMedCrossRefGoogle Scholar
  27. 27.
    Hiraoka T (1990) Extended radical resection of cancer of the pancreas with intraoperative radiotherapy. Bailliere’s Clin Gastroenterol 4:985–993.CrossRefGoogle Scholar
  28. 28.
    Bosset JF, Pavy JJ, Gillet M, Mantion G, Pelissier E, Schraub S (1992) Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study. Radiother Oncol 24:191–194.PubMedCrossRefGoogle Scholar
  29. 29.
    Brachet A, Gilly FN, Braillon G (1993) IORT and surgery for pancreatic adenocarcinoma: a series of 56 patients treated according to the Lyon intraoperative system. Digestion 54:266–267 (abstract).Google Scholar
  30. 30.
    Johnstone PA, Sindelar WF (1993) Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy correlations of a clinical trial. Int J Radiat Oncol Biol Phys 27:831 -834.PubMedCrossRefGoogle Scholar
  31. 31.
    Zerbi A, Fossati V, Parolini D et al. (1994) Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 73:2930–2935.PubMedCrossRefGoogle Scholar
  32. 32.
    Ozaki H, Kinoshita T, Kosuge T, Egawa S, Kishi K (1990) Effectiveness of multimodality treatment for resectable pancreatic cancer. Int J Pancreatol 7:195–200.PubMedGoogle Scholar
  33. 33.
    Abe M, Takahashi M (1981) Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys 7:863–868.PubMedCrossRefGoogle Scholar
  34. 34.
    GITSG (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006–2010.CrossRefGoogle Scholar
  35. 35.
    Whittington R, Bryer MP, Haller DG, Solin LJ, Rosato EF (1991) Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 21:1137–1143.PubMedCrossRefGoogle Scholar
  36. 36.
    Foo ML, Gunderson LL, Nagorney DM et al. (1993) Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil. Int J Radiat Oncol Biol Phys 26:483–489.PubMedCrossRefGoogle Scholar
  37. 37.
    Evans DB, Abbruzzese JL, Cleary KR (1995) Preoperative chemo radiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. Int J Radiat Oncol Biol Phys 33:913–918.CrossRefGoogle Scholar
  38. 38.
    Splinter TA, Obertop H, Kok TC, Jeekel J (1989) Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomised pilot study. J Cancer Res Clin Oncol 115:200–202.PubMedCrossRefGoogle Scholar
  39. 39.
    Bakkevold KE, Arnesjo B, Dahl O, Kambestad B (1993) Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater: results of a controlled, prospective, randomised multicentre study. Eur J Cancer 5:698–703.CrossRefGoogle Scholar
  40. 40.
    Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H (1994) Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 81:102–107.PubMedCrossRefGoogle Scholar
  41. 41.
    Ishikawa O, Ohigashi H, Sasaki Y et al. (1994) Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 168:361–364.PubMedCrossRefGoogle Scholar
  42. 42.
    Ohigashi H, Ishikawa O, Imaoka S et al. (1996) A new method of intraarterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer. Hepatogastroenterology 43:338–345.PubMedGoogle Scholar
  43. 43.
    Link KH, Gansuage F, Rilinger N, Beger HG (1997) Celiac artery adjuvant chemotherapy: results of a prospective trial. Int J Pancreatology 21:65–69.Google Scholar
  44. 44.
    Kaiser MH, Ellenberg SS (1985) Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899–903.Google Scholar
  45. 45.
    Yeo CJ, Abrams RA, Grochow LB et al. (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective single-institution experience. Ann Surg 225:621–636.PubMedCrossRefGoogle Scholar
  46. 46.
    UKPACA (1993) Adjuvant radiotherapy following resection of pancreatic cancer. Gut:34:1296 (abstract).Google Scholar
  47. 47.
    Neoptolemos JP, Baker P, Beger H et al. (1997) Progress report: A randomised multicentre European study comparing adjuvant radiotherapy, six months chemotherapy and combination therapy versus no adjuvant treatment in resectable pancreatic cancer. (in Int J Pancreatolpress).Google Scholar
  48. 48.
    Tempero MA, Sivinski C, Steplewski Z, Harvey E, Klassen L, Kay HD (1990) Phase II trial of interferon garAma and monoclonal antibody 17–1A in pancreatic cancer. Biologic and clinical effects. J Clin Oncol 8:2019–2026.PubMedGoogle Scholar
  49. 49.
    Büchler M, Friess H, Schultheiss HK (1991) A randomised controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer 68:1507–1517.PubMedCrossRefGoogle Scholar
  50. 50.
    Weiner LM, Harvey E, Padavic-Shaller K, Willson JK, Walsh C, Lacreta F (1993) Phase II multicenter evaluation of prolonged murine monoclonal antibody 17–1A therapy in pancreatic carcinoma. J Immunother 13:110–116.CrossRefGoogle Scholar
  51. 51.
    Bernhard H, Jagerarand E, Bernhard G et al. (1995) Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha 2A: results of a phase II trial. Br J Cancer 71:102–105.PubMedCrossRefGoogle Scholar
  52. 52.
    Wagener DJ, Verdonk HE, Dirix LY, Catimel G, Siegenthaler P, Buitenhuis M (1995) Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study. Ann Oncol 6:129–132.PubMedGoogle Scholar
  53. 53.
    Rinaldi HA, Dorr FA, Woodworth JG, Kuhn JR, Eckhardt JR (1995) Initial phase I evaluation of the novel thymidilate synthetase inhibitor, LY231514, using the modified continual reassessment method for dose escalation. J Clin Oncol 13:2842–2850.PubMedGoogle Scholar
  54. 54.
    Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31.PubMedCrossRefGoogle Scholar
  55. 55.
    Voest EE, Kenyon BM, Truitt G et al. (1995) Inhibition of angiogenesis in vivo by interleukin 12. J Nat Cancer Inst 87:581–586.PubMedCrossRefGoogle Scholar
  56. 56.
    Moore MJ, Andersen J, Burris H, Tarassoff P, Green M, Casper E (1997) A randomised trial of gemcitabine versus 5-FU as first line therapy in advanced pancreatic cancer. J Clin Oncol (in press).Google Scholar
  57. 57.
    Evans JD, Bramhall SR, Stark A et al. (1996) A phase II trial of marimastat (BB-2516) in advanced pancreatic cancer. Int J Pancreatology 19:218 (abstract).Google Scholar
  58. 58.
    Dimaio JM, Clary BM, Via DF, Coveney E, Pappas TN, Lyerly HK (1994) Directed enzyme prodrug gene therapy for pancreatic cancer in vivo. Surgery 116:205–213.PubMedGoogle Scholar
  59. 59.
    Yang L, Hwang R, Pandit L, Gordon EM, Anderson F, Parekh D (1996) Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes thymidine kinase vector supernatant and gancyclovir. Ann Surg 224:405–417.PubMedCrossRefGoogle Scholar
  60. 60.
    Green NK, Youngs DJ, Neoptolemos JP (1997) Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5(aziridin-l-yl)-2, 4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase gene. Cancer Gene Therapy (in press).Google Scholar

Copyright information

© Springer-Verlag London Limited 1999

Authors and Affiliations

  • Paula Ghaneh
  • Anthony Kawesha
  • J. D. Evans
  • J. P. Neoptolemos

There are no affiliations available

Personalised recommendations